GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nutraceutical International Corp (NAS:NUTR) » Definitions » Preferred Stock

Nutraceutical International (Nutraceutical International) Preferred Stock : $0.0 Mil (As of Jun. 2017)


View and export this data going back to 1998. Start your Free Trial

What is Nutraceutical International Preferred Stock?

Preferred stock is a special equity security that has properties of both equity and debt. Nutraceutical International's preferred stock for the quarter that ended in Jun. 2017 was $0.0 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. Nutraceutical International's Enterprise Value for the quarter that ended in Jun. 2017 was $431.9 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. Nutraceutical International's Book Value per Share for the quarter that ended in Jun. 2017 was $19.71.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). Nutraceutical International's Earnings per Share (Diluted) for the three months ended in Jun. 2017 was $0.20.


Nutraceutical International Preferred Stock Historical Data

The historical data trend for Nutraceutical International's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutraceutical International Preferred Stock Chart

Nutraceutical International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nutraceutical International Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nutraceutical International Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.


Nutraceutical International  (NAS:NUTR) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

Nutraceutical International's Enterprise Value for the quarter that ended in Jun. 2017 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

Nutraceutical International's Book Value per Share for the quarter that ended in Jun. 2017 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

Nutraceutical International's Earnings per Share (Diluted) (EPS) for the three months ended in Jun. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutraceutical International Preferred Stock Related Terms

Thank you for viewing the detailed overview of Nutraceutical International's Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutraceutical International (Nutraceutical International) Business Description

Traded in Other Exchanges
N/A
Address
Nutraceutical International Corp was incorporated in Delaware in 1993. The Company is a manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores. Internationally, it markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Its core business is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns neighborhood natural food markets, which operates under the trade names The Real Food Company, Thom's Natural Foods, Cornucopia Community Market and Granola's. It also owns health food stores, which operates under various trade names, including Fresh Vitamins and Peachtree Natural Foods. The Company's products includes vitamins and minerals, herbs, specialty formulas, personal care products, liquid nutritional products, homeopathics, functional foods and other products.
Executives
J Kimo Esplin director C/O NUTRACEUTICAL INTERNATIONAL CORP, 1400 KEARNS BLVD, PARK CITY UT 84060
Bain Capital Investors Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Iv Lp 10 percent owner C/O BAIN CAPITAL LLC, TWO COPLEY PLACE, BOSTON MA 02199
Bcip Trust Associates Lp 10 percent owner C/O BAIN CAPITAL LLC, 111 HUNINGTON AVENUE, BOSTON MA 02199
Robert C Gay director C/O BAIN CAPITAL INC TWO COPLEY PLACE, BOSTON MA 02116
Matthew S Levin director BAIN CAPITAL PARTNERS LLC JOHN HANCOCK TOWER, 200 CLARENDON STREET BOSTON MA 02116
Associates Bcip 10 percent owner

Nutraceutical International (Nutraceutical International) Headlines